Proximal Row Carpectomy vs Four-corner Fusion for Osteoarthritis of the Wrist
Launched by TÖÖLÖ HOSPITAL · Feb 5, 2020
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different surgical procedures to treat wrist osteoarthritis, specifically in patients with a condition called scapholunate advanced collapse (SLAC) or scaphoid non-union advanced collapse (SNAC). The two procedures being compared are proximal row carpectomy (PRC), which involves removing some of the wrist bones, and four-corner fusion (FCA), where several bones in the wrist are fused together to relieve pain and improve function. The goal is to see which method leads to better outcomes for patients.
To participate in the trial, you need to be between 18 and 75 years old, have had symptoms for more than three months, and have a specific type of wrist arthritis (SLAC or SNAC II-III). Unfortunately, if you have other serious wrist conditions, rheumatoid arthritis, or certain health issues that could affect healing, you wouldn’t be eligible. If you join the study, you’ll have your surgery and then attend follow-up visits at various times to monitor your recovery over the next several years. Both you and the assessors will not know which procedure you received until a year after your surgery, which helps ensure the results are unbiased.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • SLAC/SNAC II-III
- • Age 18 - 75
- • Symptom duration \> 3 months
- • American Society of Anaesthesiologists physical status (ASA) I-II
- Exclusion Criteria:
- • Patient eligible for SL reconstruction or scaphoid
- • Ulnocarpal/pancarpal arthritis
- • Lunate fossa, proximal lunate arthrosis or both
- • Age \<18 or \>75 years
- • Rheumatoid arthritis
- • Heavy smoking (\> 20 cigarettes per day)
- • Condition or medication affecting bony healing (eg diabetes mellitus with poor glycemic control, malnutrition, use of per oral corticosteroids)
- • Alcohol or drug abuse
- • Neurological condition affecting upper limb function
About Töölö Hospital
Töölö Hospital, a prominent healthcare institution located in Helsinki, Finland, is dedicated to advancing medical research and clinical practices through innovative clinical trials. With a strong emphasis on patient-centered care, Töölö Hospital combines cutting-edge medical technology with a multidisciplinary approach to enhance therapeutic outcomes. The hospital is committed to fostering collaboration between researchers, healthcare professionals, and patients, ensuring rigorous adherence to ethical standards and regulatory guidelines. Through its clinical trial initiatives, Töölö Hospital aims to contribute significantly to the advancement of medical knowledge and the development of novel treatment options.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tampere, , Finland
Turku, , Finland
Kotka, , Finland
Jyväskylä, , Finland
Helsinki, , Finland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials